SAVA Cassava Sciences
- 22.129
- -0.211-0.94%
Cassava Sciences News
Cassava Sciences Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), Repare Therapeutics (RPTX)
Analysts Are Bullish on These Healthcare Stocks: Cassava Sciences (SAVA), CymaBay Therapeutics (CBAY)
Analysts Offer Insights on Healthcare Companies: Cassava Sciences (SAVA), Kiora Pharmaceuticals (KPRX) and Bluebird Bio (BLUE)
Cassava Sciences' Simufilam Efficacy and Safety in Alzheimer's Treatment Bolsters Buy Rating: An Analysis of Trial Results and Future Projections
Positive Phase 3 Trials and Undervalued Stock: Buy Rating Suggested for Cassava Sciences
Buy Rating for Cassava Sciences: Rapid Alzheimer's Trials Progress and Strong Financial Health
Cassava Sciences (SAVA) Gets a Buy From JonesTrading
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
Cassava Sciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Stoke Therapeutics (STOK) and Cassava Sciences (SAVA)
JonesTrading Remains a Buy on Cassava Sciences (SAVA)
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
Cassava Sciences (SAVA) Receives a Buy From JonesTrading
JonesTrading Keeps Their Buy Rating on Cassava Sciences (SAVA)
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
HC Wainwright & Co. Reiterates Buy on Cassava Sciences, Maintains $124 Price Target
Analysts Have Conflicting Sentiments on These Healthcare Companies: Oncternal Therapeutics (ONCT), Cassava Sciences (SAVA) and Enanta Pharmaceuticals (ENTA)
Cassava Sciences (SAVA) Gets a Buy From JonesTrading
Analysis
Price Target
No Data
